Data / Research funding / Texas / Sanarentero LLC
Sanarentero LLC: 3 NIH awards ($907K), fiscal years 2021 to 2026
Sanarentero LLC in Pearland, TX is funded under 3 NIH awards ($907K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- NIH institution profile
- 10057560
- State
- Texas
- Note
- NIH gives no UEI for this institution, so NSF awards are not matched.
Awards
3 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Development of Drug Detoxifying Bacteria for Chemotherapy Induced Gut Injury | NIH | National Cancer Institute | 2021 to 2022 | $454,955 | September 23, 2021 | August 31, 2022 | SINGH, RASHIM | reporter.nih.gov |
| Genetic Biocontainment Switch to Improve the Safety of Drug Detoxifying Bacteria in Preventing Chemotherapy-induced Diarrhea | NIH | National Cancer Institute | 2023 | $399,999 | April 1, 2023 | March 31, 2025 | SINGH, RASHIM | reporter.nih.gov |
| Development of Novel Herbal Therapy for Prevention of Irinotecan-induced Severe Delayed Onset Diarrhea | NIH | National Center for Complementary & Integrative Health | 2021 | $52,000 | September 21, 2020 | September 20, 2022 | SINGH, RASHIM | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2023 | 1 | $399,999 | 0 | $0 |
| 2022 | 1 | $55,000 | 0 | $0 |
| 2021 | 2 | $451,955 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) | PAR-27-089 | NIH | 93.395 | November 2, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) | PAR-26-152 | NIH | 93.395 | November 11, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) | PAR-25-269 | NIH | 93.213 | November 13, 2026 | $350,000 | Same assistance listing 93.213 as 1 award here |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) | PAR-25-270 | NIH | 93.213 | November 13, 2026 | $1.1 million | Same assistance listing 93.213 as 1 award here |
| NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) | PAR-25-271 | NIH | 93.213 | November 13, 2026 | Not listed | Same assistance listing 93.213 as 1 award here |
| NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) | PAR-25-267 | NIH | 93.213 | November 17, 2026 | $350,000 | Same assistance listing 93.213 as 1 award here |
| Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) | PAR-25-268 | NIH | 93.213 | November 17, 2026 | Not listed | Same assistance listing 93.213 as 1 award here |
| Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) | PAR-25-274 | NIH | 93.213 | November 17, 2026 | Not listed | Same assistance listing 93.213 as 1 award here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.395 | November 20, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.213 | November 23, 2026 | $375,000 | Same assistance listing 93.213 as 1 award here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.213 | November 24, 2026 | Not listed | Same assistance listing 93.213 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.213 | December 4, 2026 | Not listed | Same assistance listing 93.213 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.213 | January 5, 2027 | Not listed | Same assistance listing 93.213 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.213 | January 5, 2027 | Not listed | Same assistance listing 93.213 as 1 award here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.395 | January 7, 2027 | $375,000 | Same assistance listing 93.395 as 1 award here |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | PAR-25-079 | NIH | 93.395 | January 7, 2027 | $500,000 | Same assistance listing 93.395 as 1 award here |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | PAR-25-081 | NIH | 93.395 | January 7, 2027 | $499,999 | Same assistance listing 93.395 as 1 award here |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | PAR-25-378 | NIH | 93.213 | January 7, 2027 | Not listed | Same assistance listing 93.213 as 1 award here |
| Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) | RFA-CA-27-005 | NIH | 93.395 | January 11, 2027 | $700,000 | Same assistance listing 93.395 as 1 award here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.213 | January 15, 2027 | $350,000 | Same assistance listing 93.213 as 1 award here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.